Skip to main content
Astellas Pharma Inc. logo

Astellas Pharma Inc. — Investor Relations & Filings

Ticker · 4503 ISIN · JP3942400007 LEI · 529900IB708DY2HBBB35 T Manufacturing
Filings indexed 78 across all filing types
Latest filing 2016-06-20 Annual Report
Country JP Japan
Listing T 4503

About Astellas Pharma Inc.

https://www.astellas.com/en

Astellas Pharma Inc. is a global pharmaceutical company dedicated to improving human health by turning innovative science into value for patients. The company's core activities encompass the research, development, manufacture, and commercialization of novel pharmaceutical products. Astellas focuses on pioneering transformative therapies in disease areas with high unmet medical needs, including oncology, ophthalmology, urology, immunology, and women's health. Through its patient-centric approach and robust research and development programs, the company aims to deliver innovative healthcare solutions worldwide.

Recent filings

Filing Released Lang Actions
有価証券報告書-第11期(2015/04/01-2016/03/31)
Annual Report Classification · 100% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the Japanese equivalent of a 10-K. It contains detailed financial statements, management indicators, and corporate information for the fiscal year ending March 31, 2016. It is a comprehensive annual filing submitted to the Kanto Local Finance Bureau, not an announcement or a summary. FY 2016
2016-06-20 Japanese
四半期報告書-第11期第3四半期(2015/10/01-2015/12/31)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (第3四半期報告書) for Astellas Pharma Inc., covering the third quarter of the fiscal year ending 2016. It contains detailed financial statements, including the Consolidated Statement of Profit or Loss and Comprehensive Income, and management analysis. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). 9M 2016
2016-02-08 Japanese
四半期報告書-第11期第2四半期(2015/07/01-2015/09/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed by Astellas Pharma Inc. in Japan. It contains detailed financial statements, management analysis, and audit review information for the second quarter of the fiscal year 2015. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H1 2016
2015-11-06 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.